149 related articles for article (PubMed ID: 767112)
1. The second generation of EORTC-ECIG experimental screening for systemic immunity adjuvants. Its significance for cancer immunotherapy. A comparison of BCG and its hydrosoluble extract.
Mathe G; Halle-Pannenko O; Florentin I; Bruley-Rosset M; Kamel M; Hiu IJ; Bourut C
Eur J Cancer (1965); 1975 Nov; 11(11):801-7. PubMed ID: 767112
[No Abstract] [Full Text] [Related]
2. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
Mathé G; Halle-Pannenko O; Bourut C
Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
[No Abstract] [Full Text] [Related]
3. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
[No Abstract] [Full Text] [Related]
4. Methanol extraction residue fraction of tubercle bacilli (MER) and other mycobacterial extracts as systemic immunity adjuvants in cancer immunotherapy.
Mathé G; Hiu IJ; Halle-Pannenko O; Bourut C
Isr J Med Sci; 1976; 12(4-5):468-71. PubMed ID: 820673
[TBL] [Abstract][Full Text] [Related]
5. An experimental screening for "systemic adjuvants of immunity" applicable in cancer immunotherapy.
Mathé G; Kamel M; Dezfulian M; Halle-Pannenko O; Bourut C
Cancer Res; 1973 Sep; 33(9):1987-97. PubMed ID: 4146853
[No Abstract] [Full Text] [Related]
6. Immunotherapy of guinea pig cancer with BCG.
Zbar B
Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
[No Abstract] [Full Text] [Related]
7. Activated macrophages and the antitumor action of BCG.
Alexander P
Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
[No Abstract] [Full Text] [Related]
8. Experimental and clinical trials with BCG immunotherapy.
Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
[No Abstract] [Full Text] [Related]
9. Nonspecific macrophage activation by systemic adjuvants. Evaluation by lysosomal enzyme and in vitro tumoricidal activities.
Bruley-Rosset M; Florentin I; Khalil AM; Mathé G
Int Arch Allergy Appl Immunol; 1976; 51(5):594-607. PubMed ID: 786904
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro macrophage activation by systemic adjuvants.
Bruley-Rosset M; Florentin I; Mathé G
Agents Actions; 1976 Feb; 6(1-3):251-5. PubMed ID: 782207
[TBL] [Abstract][Full Text] [Related]
11. Immunological intervention in neoplasia.
Weiss DW
Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
[No Abstract] [Full Text] [Related]
12. Adjuvant and antitumor activities of Nocardia cell-wall skeletons.
Azuma I; Taniyama T; Yamawaki M; Sugimura K; Yamamura Y
Gan; 1976 Oct; 67(5):733-6. PubMed ID: 797626
[TBL] [Abstract][Full Text] [Related]
13. Tumor immunity induced by BCG-tumor cell mixtures in syngeneic mice.
Tokunaga T; Kataoka T; Nakamura RM; Yamamoto S; Tanaka T
Jpn J Med Sci Biol; 1973 Apr; 26(2):71-85. PubMed ID: 4585343
[No Abstract] [Full Text] [Related]
14. [Comparative antitumoral cytostatic effect of splenic or peritoneal cells of mice with teratocarcinoma or immunized with tumoral cells. Stimulating effect of BCG and cyclophosphamide].
Christen Y
C R Acad Hebd Seances Acad Sci D; 1974 Nov; 279(22):1729-32. PubMed ID: 4219181
[No Abstract] [Full Text] [Related]
15. Comparison between the effects of Micrococcus, BCG and related polysaccharides in preclinical chemo-immunotherapy of murine L 1210 leukaemia [proceedings].
Verloes R; Atassi G; Dumont P; Kanarek L
Arch Int Physiol Biochim; 1978 Oct; 86(4):969-71. PubMed ID: 84653
[No Abstract] [Full Text] [Related]
16. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
[TBL] [Abstract][Full Text] [Related]
17. Immunology and colonic cancer: cancer immunotherapy results in leukemias--experimental and clinical approaches to the treatment of solid tumors.
Mathé G; Thompson RB
Dis Colon Rectum; 1973; 16(5):341-57. PubMed ID: 4590448
[No Abstract] [Full Text] [Related]
18. BCG in tumor immunotherapy.
Baldwin RW; Pimm MV
Adv Cancer Res; 1978; 28():91-147. PubMed ID: 360797
[No Abstract] [Full Text] [Related]
19. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
[No Abstract] [Full Text] [Related]
20. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
[No Abstract] [Full Text] [Related]
[Next] [New Search]
